S. Holtan

发表

Diagnosis of obesity by primary care physicians and impact on obesity management.

Jeffrey M Slezak, Warren G Thompson, Aditya Bardia, 2007, Mayo Clinic proceedings.

PlGF enhances TLR‐dependent inflammatory responses in human mononuclear phagocytes

J. Tyner, I. Burd, L. Newell, 2017, American journal of reproductive immunology.

Inadequate survivorship care after allogeneic hematopoietic cell transplantation: A retrospective chart review

A. Blaes, Michael J Franklin, Q. Cao, 2018, F1000Research.

Acute graft-versus-host disease: a bench-to-bedside update.

M. Pasquini, D. Weisdorf, S. Holtan, 2014, Blood.

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

Ed S. McCarron, C. Slingluff, K. Lewis, 2021, Journal for ImmunoTherapy of Cancer.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Bone Marrow Transplantation.

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma

M. Thompson, S. Markovic, D. Creedon, 2011, Clinical & developmental immunology.

The dynamic human immune response to cancer: it might just be rocket science.

James D. Turner, H. Frisch, A. Mansfield, 2011, Immunotherapy.

Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplant Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation

Robin R. Shields-Cutler, D. Longo, D. Knights, 2020, Science Translational Medicine.

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402

G. Vercellotti, M. MacMillan, Juan Wu, 2017, Bone Marrow Transplantation.

A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality

M. Robin, M. Pasquini, Richard J. Jones, 2015 .

Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802 Biol Blood Marrow Transplant .

Gabrielle, Meyers, G. Vercellotti, 2015 .

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

M. Goetz, N. Foster, C. Erlichman, 2012, PloS one.

Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma

A. Leontovich, S. Markovic, W. Nevala, 2016, Melanoma research.

Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

P. Haluska, S. Markovic, D. Creedon, 2009, Mayo Clinic proceedings.

Do Cancer and Cancer Treatments Accelerate Aging?

A. Blaes, Roma Bhatia, A. Prizment, 2022, Current Oncology Reports.

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

B. Storer, T. Panzarella, M. Aljurf, 2016, Blood.

Lasting shift in the gut microbiota in patients with acute myeloid leukemia

A. Khoruts, C. Staley, D. Weisdorf, 2022, Blood advances.

Food‐frequency questionnaire‐based estimates of total antioxidant capacity and risk of non‐Hodgkin lymphoma

J. Cerhan, T. Habermann, S. Slager, 2012, International journal of cancer.

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2021, Blood advances.

Chronic Graft-Versus-Host Disease

S. Holtan, J. Brammer, 2015 .

Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation.

A. Khoruts, C. Staley, M. MacMillan, 2022, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation

A. Khoruts, C. Staley, D. Weisdorf, 2019, Cancer.

Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia

A. Khoruts, C. Staley, D. Weisdorf, 2022, Scientific Data.

Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena.

C. Mullany, K. Chandrasekaran, A. Kamal, 2007, International journal of cardiology.

The Endothelium During Allogeneic Stem Cell Transplantation

S. Holtan, O. Penack, 2019, Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2020, Bone Marrow Transplantation.

Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia.

G. Vercellotti, M. Reding, S. Holtan, 2019, Blood cells, molecules & diseases.

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

M. Fishman, S. Patel, G. Daniels, 2019, Journal of Immunotherapy for Cancer.

Immunomodulation in COVID-19

R. Dudley, C. Tignanelli, S. Holtan, 2020, The Lancet Respiratory Medicine.

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2019, JCI insight.

Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.

R. Corvò, G. Storme, K. Dusenbery, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin‐associated thrombocytopenia

A. Tefferi, S. Holtan, S. Knox, 2006, Journal of Thrombosis and Haemostasis.

Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q

D. Steensma, A. Tefferi, J. Hoyer, 2009, Leukemia.

Circulating bacterial DNA and neutropenic fever during anti‐leukaemia chemotherapy

A. Khoruts, C. Staley, D. Weisdorf, 2020, British Journal of Haematology.

Mother knows best: lessons from fetomaternal tolerance applied to cancer immunity.

D. Creedon, S. Holtan, 2011, Frontiers in bioscience.

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality.

D. Weisdorf, B. Blazar, T. DeFor, 2020, Blood advances.

Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease: single-center results from a cohort of 203 patients.

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biomarkers in Graft-Versus-Host Disease: from Prediction and Diagnosis to Insights into Complex Graft/Host Interactions

S. Holtan, Fiona He, 2018, Current Hematologic Malignancy Reports.

Adult Hematology/Oncology Patient Perspectives on Telemedicine Highlight Areas of Focus for Future Hybrid Care Models.

B. Lindgren, J. Hui, A. Blaes, 2022, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

W. Wood, B. Storer, J. Pidala, 2016, Blood.

Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis

A. Mansfield, S. Markovic, L. Erickson, 2011, Modern Pathology.

Do Cancer and Cancer Treatments Accelerate Aging?

A. Blaes, Roma Bhatia, A. Prizment, 2022, Current Oncology Reports.

Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease

C. Brunstein, S. Holtan, Allison P Watson, 2018, Case reports in transplantation.

Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-transplant serum citrulline predicts acute graft-versus-host disease

A. Khoruts, D. Weisdorf, B. Blazar, 2018 .

Treatment of CSF1R‐Related Leukoencephalopathy: Breaking New Ground

E. Middlebrooks, Z. Wszolek, B. K. Rush, 2021, Movement disorders : official journal of the Movement Disorder Society.

Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant.

Jeffrey S. Miller, M. MacMillan, Juan Wu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An organ system based approach to prognosis in advanced melanoma.

A. Mansfield, A. Leontovich, P. Haluska, 2012, Frontiers in bioscience.

Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.

D. Weisdorf, M. Arora, A. Rashidi, 2021, Transplantation and cellular therapy.

Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reply to “Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R‐Related Leukoencephalopathy”

E. Middlebrooks, Z. Wszolek, B. K. Rush, 2022, Movement disorders : official journal of the Movement Disorder Society.

mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein‐Barr virus‐driven lymphoproliferative disorders (EBV‐LPD)

T. Habermann, S. Markovic, C. Zent, 2008, American journal of hematology.

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce

N. Geller, P. Hari, D. Porter, 2019, The Lancet. Haematology.

Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.

M. Arora, S. Holtan, 2016, Translational research : the journal of laboratory and clinical medicine.

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

G. Vercellotti, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients

S. Bhatia, D. Weisdorf, M. Arora, 2022, Bone Marrow Transplantation.

Hematopoietic Cell Transplant Related Toxicities and Mortality in Frail Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML.

M. Mohty, C. Hourigan, U. Borate, 2021, Blood advances.

Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell Transplantation.

S. Holtan, R. Kao, 2019, Infectious disease clinics of North America.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors

V. Velcheti, M. Ernstoff, Jeffrey S. Miller, 2018, Clinical Cancer Research.

Urinary-derived human chorionic gonadotropin to induce tolerance and promote healing in steroid-refractory GvHD

S. Holtan, A. Panoskaltsis‐Mortari, 2016, Bone Marrow Transplantation.

Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

S. Ognjanovic, S. Markovic, D. Creedon, 2014, Mayo Clinic proceedings.

Placental growth factor: What hematologists need to know.

L. Newell, S. Holtan, 2017, Blood reviews.

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

D. Weisdorf, M. Arora, A. Rashidi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Growth Modeling of the Maternal Cytokine Milieu throughout Normal Pregnancy: Macrophage-Derived Chemokine Decreases as Inflammation/Counterregulation Increases

S. Markovic, D. Creedon, Yiyi Chen, 2015, Journal of immunology research.

Neuro-endocrine-immune Crosstalk and Implications for Cancer Therapy

S. Markovic, R. Dronca, S. Holtan, 2011 .

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics

S. Markovic, W. Nevala, S. Holtan, 2015, Front. Immunol..

Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota

D. Knights, A. Khoruts, K. Hippen, 2017, Translational research : the journal of laboratory and clinical medicine.

Evaluation of Functional Marrow Irradiation Based on Skeletal Marrow Composition Obtained Using Dual-Energy Computed Tomography.

G. Storme, K. Dusenbery, K. Nakagawa, 2016, International journal of radiation oncology, biology, physics.

Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements

A. Israni, A. Khoruts, C. Staley, 2022, Gut microbes.

Upper GI GVHD: similar outcomes to other grade II graft-versus-host disease

D. Weisdorf, R. Mehta, Q. Cao, 2017, Bone Marrow Transplantation.

Levaquin gets a pass.

A. Khoruts, C. Staley, D. Weisdorf, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fetal Sex-Based Differences in Maternal Hormones, Angiogenic Factors, and Immune Mediators During Pregnancy and the Postpartum Period

S. Markovic, D. Creedon, W. Nevala, 2014, American journal of reproductive immunology.

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

A. Tefferi, J. Hoyer, D. Caramazza, 2010, Leukemia.

Repairing Damaged Goods: Mesenchymal Stromal Cell Therapy for Secondary Failure of Hematopoiesis Post-Allogeneic Hematopoietic Cell Transplant

S. Markovic, L. Newell, S. Holtan, 2012 .

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant.

W. Hogan, M. Litzow, S. Holtan, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

Pediatric acute GVHD: clinical phenotype and response to upfront steroids

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Bone Marrow Transplantation.

Validation of Minnesota acute graft-versus-host disease Risk Score

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Haematologica.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

M. Robin, M. Pasquini, Richard J. Jones, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies

S. Ansell, M. Lacy, W. Hogan, 2010, Bone Marrow Transplantation.

Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid

A. Khoruts, C. Forster, M. MacMillan, 2018, Modern Pathology.

A risk-adapted approach to acute GVHD treatment: are we there yet?

M. MacMillan, S. Holtan, M. MacMillan, 2016, Bone Marrow Transplantation.

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Blood advances.

Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501.

E. Leifer, M. Horowitz, J. Pidala, 2019, Blood.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning

M. Patnaik, W. Hogan, M. Litzow, 2013, Bone Marrow Transplantation.

Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of clinical factors and allograft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blood haematopoietic cell transplant

M. Patnaik, W. Hogan, M. Litzow, 2014, BMC Hematology.

Necessity for treatment of steroid refractory severe GIT GVHD: patience of providers

D. Weisdorf, A. Rashidi, C. Ustun, 2019, Bone Marrow Transplantation.

Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic malignancies.

M. Arora, V. Bachanova, Q. Cao, 2021, Transplantation and cellular therapy.

Low 5-year health care burden after umbilical cord blood transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Blood advances.

Gut microbiota response to antibiotics is personalized and depends on baseline microbiota

A. Khoruts, C. Staley, D. Weisdorf, 2021, Microbiome.

Stress responses , M 2 macrophages , and a distinct microbial signature in fatal intestinal acute graft-versus-host disease

A. Khoruts, M. MacMillan, D. Weisdorf, 2019 .

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

Acute GVHD: think before you treat.

L. Newell, S. Holtan, 2021, Hematology. American Society of Hematology. Education Program.

Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanoma

J. Ingle, H. Pitot, S. Markovic, 2006, Cancer.

Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count

D. Steensma, A. Tefferi, S. Markovic, 2010, American journal of hematology.

Prevention of graft versus host disease with Hematopoietic CellTransplantation with Reduced Intensity Conditioning—a comparison of threeprophylaxis regimens (tacrolimus/mycophenolate mofetil/cyclophosphamide,tacrolimus/methotrexate/bortezomib or tacrolimus/methotrexate/maraviroc) versustacrolimus/me

N. Geller, P. Hari, M. Pasquini, 2019 .

Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

K. Dusenbery, D. Weisdorf, M. Verneris, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice

G. Storme, S. Hui, S. Dandapani, 2022, Frontiers in Oncology.

Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents.

G. Storme, P. Alaei, Daohong Zhou, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report from the BMT CTN Patient and Caregiver Advocacy Task Force.

A. Shimamura, N. Mortier, B. Nuechterlein, 2022, Transplantation and cellular therapy.

The Perfect Transplant.

S. Holtan, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

S. Sebti, J. Pidala, A. Mishra, 2021, Clinical Cancer Research.

AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma.

S. Markovic, D. Gastineau, D. Inwards, 2007, Clinical lymphoma & myeloma.

Solid Organ Transplant Graft-Versus-Host Disease in a Kidney/Pancreas Transplant Patient: Use of Chimerism Testing and a Rare Presentation of Cutaneous GVHD

C. Lian, R. Kandaswamy, E. Finger, 2022, Case Reports in Transplantation.

Steroid sensitive acute GVHD, but not steroid dependent or steroid resistant, results in similar infection risk as no GVHD following allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, M. Arora, 2022, Transplantation and cellular therapy.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PHASE I TRIAL OF ALT-803, A NOVEL RECOMBINANT INTERLEUKIN-15 COMPLEX, IN PATIENTS WITH ADVANCED SOLID TUMORS

V. Velcheti, M. Ernstoff, Jeffrey S. Miller, 2018 .

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia

Robin R. Shields-Cutler, A. Khoruts, C. Staley, 2019, Scientific Reports.

Effect of COVID-19 precautions on the gut microbiota and nosocomial infections

A. Khoruts, C. Staley, D. Weisdorf, 2021, Gut microbes.

Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.

D. Weisdorf, T. DeFor, Z. Sachs, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Journal of cutaneous pathology.

Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703

M. Perales, Richard J. Jones, Y. Efebera, 2022, Blood.

Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.

D. Steensma, A. Tefferi, G. Dewald, 2008, Leukemia research.

Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.

D. Steensma, A. Tefferi, G. Dewald, 2008, Leukemia research.

Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review

Jingbo Yu, Dilan Paranagama, A. Naim, 2022, Bone Marrow Transplantation.

W. Wood, H. Jim, J. Wingard, 2022, Transplantation and cellular therapy.

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Bone Marrow Transplantation.

From frail to fit after allogeneic hematopoietic cell transplantation: Scope of the problem and a strength-based solution

M. Arora, Q. Cao, S. Holtan, 2019, medRxiv.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

J. Kanda, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

Vorinostat is victorious in GVHD prevention.

D. Weisdorf, S. Holtan, 2017, Blood.

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers

A. Bhatt, D. Weisdorf, A. Rashidi, 2018, American journal of hematology.

Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant

J. Hoyer, F. Buadi, S. Holtan, 2011, Bone Marrow Transplantation.

Loss of microbiota-derived protective metabolites after neutropenic fever

A. Khoruts, C. Staley, S. Ramamoorthy, 2022, Scientific Reports.

Perspectives of cancer patients and their health during the COVID-19 pandemic

H. Nelson, R. Vogel, J. Hui, 2020, PloS one.

Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia

A. Khoruts, C. Staley, S. Ramamoorthy, 2021, Blood advances.

Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy

A. Khoruts, C. Staley, D. Weisdorf, 2019, Leukemia.

Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma

S. Ansell, S. Markovic, D. Gastineau, 2006, British journal of haematology.

Whole-Body Distribution of Leukemia and Functional Total Marrow Irradiation Based on FLT-PET and Dual-Energy CT

K. Dusenbery, M. Verneris, S. Hui, 2017, Molecular imaging.

Perspectives of Cancer Patients and Their Health during the COVID-19 Pandemic

H. Nelson, R. Vogel, J. Hui, 2020, medRxiv.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

J. Wagner, Chi Chen, G. Vercellotti, 2020, Blood advances.

Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study

Jingbo Yu, Dilan Paranagama, A. Naim, 2022, Bone Marrow Transplantation.

Effect of AMD3100 on T Lymphocyte Subpopulations in Apheresis Products of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Non Hodgkin Lymphoma.

A. Dispenzieri, Shaji K. Kumar, M. Gertz, 2005 .

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate

C. Ebens, S. Terezakis, V. Bachanova, 2022, medRxiv.

Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis

Robin R. Shields-Cutler, D. Knights, A. Khoruts, 2020, British journal of haematology.

Pre-transplant recovery of microbiome diversity without recovery of the original microbiome

A. Khoruts, C. Staley, D. Weisdorf, 2018, Bone Marrow Transplantation.

Application of Path-Goal and Transformational Leadership Theory to Improve Patient and Provider Satisfaction with APP-Led Survivorship Care: A Quality Improvement Initiative

S. Holtan, Sasha Skendzel, P. Finch-Guthrie, 2019, Biology of Blood and Marrow Transplantation.

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.

W. Wood, H. Jim, J. Wingard, 2023, Transplantation and cellular therapy.

Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.

R. Assi, Q. Cao, S. Holtan, 2022, Transplantation and cellular therapy.

Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-Versus-Host Disease.

M. MacMillan, D. Weisdorf, B. Blazar, 2023, Transplantation and cellular therapy.

Knowing too much

P. Mehta, S. Holtan, 2007, Journal of Cancer Education.

Chronic GvHD-associated serositis and pericarditis

S. Heitner, L. Newell, J. Gajewski, 2013, Bone Marrow Transplantation.

Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

D. Weisdorf, J. Cornelissen, S. Holtan, 2021, Journal of Clinical Oncology.

Cross-sectional study of physical activity among long-term melanoma survivors and population controls

R. Vogel, R. Ahmed, D. Lazovich, 2022, Archives of Dermatological Research.

Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML

A. Khoruts, David Kazadi, D. Weisdorf, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

R. Varadhan, C. Huff, M. Perales, 2023, The New England journal of medicine.

Mother knows best: Lessons from fetomaternal tolerance applied to cancer immunity

D. Creedon, S. Holtan, 2011 .

Graft vs GIST?

S. Okuno, W. Hogan, S. Holtan, 2012, Bone Marrow Transplantation.

Failure of front-line autologous transplant in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma

A. Feldman, R. Ketterling, S. Holtan, 2011, Bone Marrow Transplantation.

Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

C. Ebens, G. Vercellotti, Jeffrey S. Miller, 2023, Transplantation and cellular therapy.

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era

D. Steensma, A. Tefferi, G. Dewald, 2008, American journal of hematology.

Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy

A. Khoruts, C. Staley, D. Weisdorf, 2019, PloS one.

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia

Robin R. Shields-Cutler, A. Khoruts, C. Staley, 2019, Scientific Reports.

Temporal variation in oral microbiome composition of patients undergoing autologous hematopoietic cell transplantation with keratinocyte growth factor

V. Bachanova, S. Holtan, J. Maakaron, 2023, BMC Microbiology.

Pre‐transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft‐versus‐host disease

Benjamin M Hillmann, Robin R. Shields-Cutler, A. Khoruts, 2023, British journal of haematology.

ADVANCES IN HEMATOPOIETIC CELL TRANSPLANTATION Acute graft-versus-host disease: a bench-to-bedside update

M. Pasquini, S. Holtan, D. Weisdorf, 2014 .

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

M. Perales, Richard J. Jones, J. Bolaños-Meade, 2023, The New England journal of medicine.

A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement

E. Shpall, A. Alousi, G. Socié, 2023, Bone Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The development and flux of the University of Minnesota Survivorship Program: progress, challenges, and opportunities

S. Holtan, Ashley Schempp, Sasha Skendzel, 2024, Journal of cancer survivorship : research and practice.

Evaluation of Functional Marrow Irradiation Based on Skeletal Marrow Composition Obtained Using Dual-Energy Computed Tomography.

G. Storme, K. Dusenbery, K. Nakagawa, 2016, International journal of radiation oncology, biology, physics.

The best GVHD prophylaxis: Or at least progress towards finding it.

S. Holtan, N. El Jurdi, Daniel J Weisdorf, 2023, Best practice & research. Clinical haematology.

The dynamic human immune response to cancer: it might just be rocket science.

James D. Turner, H. Frisch, A. Mansfield, 2011, Immunotherapy.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Outcomes of human leukocyte antigen-matched related donor and haploidentical allogeneic hematopoietic cell transplantation recipients by immune profiles of recipients and donors.

J. Tario, T. Hahn, S. Holtan, 2024, Transplantation and cellular therapy.